Israel Englander’s PRA Health Sciences, Inc. PRAH Stock Holding History

Israel Englander’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-15,000	Closed	-$1.88M	–	6797
2020 Q4	$1.88M	Buy	15,000 +5,000	+50%	+$559K	﹤0.01%	3288
2020 Q3	$1.01K	Buy	+10,000	New	+$1.02M	﹤0.01%	3122
2020 Q1	–	Sell	-20,000	Closed	-$2.22M	–	4787
2019 Q4	$2.22M	Buy	+20,000	New	+$2.06M	﹤0.01%	2557
2019 Q2	–	Sell	-10,000	Closed	-$1.1M	–	4672
2019 Q1	$1.1M	Buy	+10,000	New	+$1.05M	﹤0.01%	2803

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Israel Englander's PRAH Position: Q3 2021 in Review

Israel Englander sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 3,730,627 shares — an estimated $616M sold.

Israel Englander first reported a position in PRAH in Q4 2014 and held it in 26 quarters. The position peaked at $616M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Israel Englander reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Israel Englander sold 3,730,627 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $616M.
Israel Englander first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 26 quarters.
Israel Englander's PRA Health Sciences, Inc. position peaked at $616M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.